Mortality Benefits From Implantable Cardioverter-Defibrillator Therapy Are Not Restricted to Patients With Remote Myocardial Infarction: An Analysis From the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
Heart Rhythm - Netherlands
doi 10.1016/j.hrthm.2010.11.033
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2011
Authors
Publisher
Elsevier BV